Welcome to our dedicated page for Walgreen Boots SEC filings (Ticker: WBA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Walgreens Boots Alliance, Inc. filings document the company's transition out of public-company reporting after its acquisition by Sycamore Partners. The record includes Form 25 delisting materials for WBA common stock and listed notes on Nasdaq and Form 15 certification covering termination of registration or suspension of Exchange Act reporting duties.
WBA's 8-K filings also disclose material events tied to the transaction period, including shareholder voting matters, temporary suspension of trading under employee benefit plans, material agreements, capital-structure matters and operating results. The filings identify covered securities such as common stock and multiple Walgreens Boots Alliance and Walgreen Co. senior notes.
Walgreens Boots Alliance, Inc. (WBA) appears in a Form 25 notification filed with the SEC to remove a class of its securities from listing and/or registration on the Nasdaq Stock Market LLC. The filing identifies the issuer's principal office at 200 Wilmot Road, Deerfield, Delaware, and notes that Nasdaq certifies it has complied with the rules under 17 CFR 240.12d2-2(b) and that the issuer has complied with 17 CFR 240.12d-2(c) for voluntary withdrawal procedures. The document does not state which specific class of securities is being removed, the effective date, or the reason for removal.
Robert Luther Huffines, a director of Walgreens Boots Alliance, Inc. (WBA), received an annual phantom stock grant reported on Form 4 with a transaction date of 08/13/2025. The grant comprised 16,820.86 phantom stock units with an attributed price of $11.89 per underlying share; each phantom unit is the economic equivalent of one share of common stock. The units are to be settled following termination of service under the company’s 2021 Omnibus Incentive Plan. After this grant, Mr. Huffines’ total phantom stock units beneficially owned are 46,813.12, which includes units issued in lieu of dividends.
Walgreens Boots Alliance director Ginger L. Graham was granted 16,820.86 phantom stock units on 08/13/2025 as non-employee director compensation under the company's 2021 Omnibus Incentive Plan. Each phantom unit is the economic equivalent of one share of common stock and will be settled following termination of service in accordance with the Plan. The reported per-unit value for the grant is $11.89, and the filing shows 112,782.56 phantom stock units beneficially owned following the transaction, which includes units issued in lieu of dividends.
The Form 4 was signed on behalf of Ms. Graham by an attorney-in-fact, Paul Ingram, on 08/15/2025. The filing is a routine disclosure of director compensation and deferred equity-like awards under the issuer’s director pay framework.
Janice M. Babiak, a director of Walgreens Boots Alliance, Inc. (WBA), received an annual grant of phantom stock units as director compensation. The Form 4 reports a grant dated 08/13/2025 of 16,820.86 phantom stock units, each economically equivalent to one share of common stock and priced at $11.89 for reporting purposes. After this award, Ms. Babiak beneficially owns 99,494.27 phantom stock units, which include units issued in lieu of dividends. The units are payable following termination of director service under the company’s 2021 Omnibus Incentive Plan. The Form 4 is signed on behalf of Ms. Babiak by an attorney-in-fact.
Walgreens Boots Alliance director Bryan C. Hanson received an annual non-employee director share grant of 16,820 common shares on 08/13/2025 as compensation for prior-year services under the company's 2021 Omnibus Incentive Plan. The grant carried a reported price of $0, reflecting compensation rather than a cash purchase, and increased Mr. Hanson’s total beneficial ownership to 47,655 shares. The Form 4 reports the transaction type as an award for director compensation and identifies the reporting person as a company director.
Valerie B. Jarrett, a director of Walgreens Boots Alliance (WBA), received an annual grant of phantom stock units as director compensation. On 08/13/2025 she was granted 16,820.86 phantom stock units, each economically equivalent to one share of WBA common stock, at a reported per-unit price of $11.89. The units are to be settled following termination of her service under the companys 2021 Omnibus Incentive Plan and include units issued in lieu of dividends. After the grant Jarrett beneficially owned 86,025.29 phantom stock units. The Form 4 was signed on 08/15/2025 by an attorney-in-fact.
Inderpal S. Bhandari, a director of Walgreens Boots Alliance, Inc. (WBA), received an annual phantom stock grant on 08/13/2025 as non-employee director compensation under the company's 2021 Omnibus Incentive Plan. The report shows 16,820.86 phantom stock units were acquired at an economic price of $11.89 per unit, and the reporting person now beneficially owns 49,779.04 phantom stock units. Each phantom stock unit is the economic equivalent of one share and these units are to be settled following termination of director service according to the Plan. The grant includes units issued in lieu of dividends on outstanding phantom stock units.
John Anthony Lederer, a director of Walgreens Boots Alliance, received an annual grant of 16,820.86 phantom stock units dated 08/13/2025 as non-employee director compensation under the company's 2021 Omnibus Incentive Plan. Each unit is economically equivalent to one share of common stock and the grant is paid in arrears for prior-year services. The phantom units vest to be settled following termination of director service and include additional units issued in lieu of dividends. The filing reports 125,173.95 common stock equivalents beneficially owned after the grant. The Form 4 was signed on behalf of Mr. Lederer by an attorney-in-fact on 08/15/2025.
Thomas E. Polen Jr., a director of Walgreens Boots Alliance, acquired equity compensation on 08/13/2025. The filing shows an annual non-employee director stock award of 11,774 common shares issued under the company's 2021 Omnibus Incentive Plan for services rendered the prior year, and an annual phantom stock grant of 5,046.26 units, each unit economically equivalent to one share. Following these grants, Mr. Polen beneficially owned 28,269 common shares and 12,356.58 shares represented by phantom units (including units issued in lieu of dividends). The phantom units are to be settled following termination of director service per the Plan.
William H. Shrank, a director of Walgreens Boots Alliance, Inc. (WBA), received an annual grant of 16,820.86 phantom stock units on 08/13/2025 as non-employee director compensation under the company's 2021 Omnibus Incentive Plan. Each phantom stock unit is the economic equivalent of one share of WBA common stock and the reported per-unit valuation is $11.89. The units are classified as derivative securities and are to be settled following termination of Shrank's service as a director in accordance with the Plan. The Form 4 was signed on 08/15/2025 by William Shrank via attorney-in-fact Cherita Thomas.